Patent ID: RE45174

Claim:
A pharmaceutical composition containing at least one thiazolidin-4-one derivative of the Formula (I) wherein: R 1 represents lower alkenyl; cycloalkyl; 5,6,7,8-tetrahydronaphth-1-yl; 5,6,7,8-tetrahydronaphth-2-yl; a phenyl group; or a phenyl group independently mono-, di- or tri-substituted with lower alkyl, halogen, lower alkoxy, or —CF 3 ; R 2 represents lower alkyl; allyl; cyclopropyl; cyclobutyl; cyclopentyl; or mono- or di-lower alkylamino; R 3 represents —NR 5 R 6 ; R 4 represents hydrogen; hydroxy; lower alkoxy; lower alkyl; or halogen; or R 3 and R 4 together may form a methylenedioxy or ethylenedioxy ring optionally further substituted with a hydroxy-methyl group; and R 5 and R 6 each represents independently lower alkyl; or configurational isomers, optically pure enantiomers, mixtures of enantiomers, enantiomeric racemates, diastereomers, mixtures of diastereomers, diastereomeric racemates, or mixtures of diastereomeric racemates, in free or pharmaceutically acceptable salt form , and an inert carrier material.